Interpreting cardiac troponin results from high-sensitivity assays in chronic kidney disease without acute coronary syndrome

Clinical Chemistry

Volumn 58, Issue 9, 2012, Pages 1342-1351

  DeFilippi, Christopher ^a   Seliger, Stephen L ^a   Kelley, Walter ^a   Duh, Show Hong ^a   Hise, Michael ^a   Christenson, Robert H ^a   Wolf, Myles ^b   Gaggin, Hanna ^c   Januzzi, James ^c  

^a UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^c MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; CREATININE; TROPONIN I; TROPONIN T;

ACUTE CORONARY SYNDROME; ADULT; AGED; ARTICLE; ASSAY; BLOOD LEVEL; CHRONIC KIDNEY DISEASE; COMPUTER ASSISTED TOMOGRAPHY; CORONARY ARTERY CALCIFICATION; CORRELATION COEFFICIENT; DIAGNOSTIC VALUE; DISEASE ASSOCIATION; ECHOCARDIOGRAPHY; FEMALE; GLOMERULUS FILTRATION RATE; HEART INFARCTION; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE MASS; HEART MUSCLE REVASCULARIZATION; HUMAN; KIDNEY FUNCTION; MAJOR CLINICAL STUDY; MALE; QUANTITATIVE ANALYSIS; RISK FACTOR; SCORING SYSTEM; SENSITIVITY ANALYSIS;

ACUTE CORONARY SYNDROME; AGED; FEMALE; HUMANS; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; SENSITIVITY AND SPECIFICITY; TROPONIN I; TROPONIN T;

EID: 84865770645     PISSN: 00099147     EISSN: 15308561     Source Type: Journal    
DOI: 10.1373/clinchem.2012.185322     Document Type: Article

References (29)

1. McCullough PA, Li S, Jurkovitz CT, Stevens L, Collins AJ, Chen SC, et al. Chronic kidney disease, prevalence of premature cardiovascular disease, and relationship to short-term mortality. Am Heart J 2008;156:277- 83.
2. Sarnak MJ, Levey AS, Schoolwerth AC, Coresh J, Culleton B, Hamm LL, et al. Kidney disease as a risk factor for development of cardiovascular disease: a statement from the American Heart Association Councils on Kidney in Cardiovascular Disease, High Blood Pressure Research, Clinical Cardiology, and Epidemiology and Prevention. Circulation 2003;108:2154-69.
3. Hostetter TH. Chronic kidney disease predicts cardiovascular disease. N Engl J Med 2004;351: 1344-6.
4. McCullough PA, Li S, Jurkovitz CT, Stevens LA, Wang C, Collins AJ, et al. CKD and cardiovascular disease in screened high-risk volunteer and general populations: the kidney early evaluation program (KEEP) and national health and nutrition examination survey (NHANES) 1999-2004. Am J Kidney Dis 2008;51:S38-45.
5. Kelley WE, Januzzi JL, Christenson RH. Increases of cardiac troponin in conditions other than acute coronary syndrome and heart failure. Clin Chem 2009;55:2098 -112.
6. Mutluay R, Konca C, Erten Y, Pasaoglu H, Deger SM, Agirgun C, et al. Predictive markers of asymptomatic atherosclerosis in end-stage renal disease patients. Ren Fail 2010;32:448 -54.
7. Thygesen K, Alpert JS, White HD, Jaffe AS, Apple FS, Galvani M, et al. Universal definition of myocardial infarction. Circulation 2007;116:2634 -53.
8. Morrow DA, Antman EM. Evaluation of highsensitivity assays for cardiac troponin. Clin Chem 2009;55:5- 8.
9. McGill D, Talaulikar G, Potter JM, Koerbin G, Hickman PE. Over time, high-sensitivity TnT replaces NT-proBNP as the most powerful predictor of death in patients with dialysis-dependent chronic renal failure. Clin Chim Acta 2010;411: 936-9.
10. Levey AS, Bosch JP, Lewis JB, Greene T, Rogers N, Roth D. A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group. Ann Intern Med 1999;130:461-70.
11. Giannitsis E, Kurz K, Hallermayer K, Jarausch J, Jaffe AS, Katus HA. Analytical validation of a high-sensitivity cardiac troponin T assay. Clin Chem 2010;56:254-61.
12. Casals G, Filella X, Bedini JL. Evaluation of a new ultrasensitive assay for cardiac troponin I. Clin Biochem 2007;40:1406 -13.
13. Hermsen D, Apple F, Garcia-Beltran L, Jaffe A, Karon B, Lewandrowski E, et al. Results from a multicenter evaluation of the 4th generation Elecsys Troponin T assay. Clin Lab 2007;53:1-9.
14. Stevens LA, Coresh J, Schmid CH, Feldman HI, Froissart M, Kusek J, et al. Estimating GFR using serum cystatin C alone and in combination with serum creatinine: a pooled analysis of 3,418 individuals with CKD. Am J Kidney Dis 2008;51: 395-406.
15. Myers GL, Miller WG, Coresh J, Fleming J, Greenberg N, Greene T, et al. Recommendations for improving serum creatinine measurement: a report from the laboratory working group of the national kidney disease education program. Clin Chem 2006;52:5-18.
16. Gutierrez OM, Januzzi JL, Isakova T, Laliberte K, Smith K, Collerone G, et al. Fibroblast growth factor 23 and left ventricular hypertrophy in chronic kidney disease. Circulation 2009;119: 2545-52.
17. Agatston AS, Janowitz WR, Hildner FJ, Zusmer NR, Viamonte M Jr, Detrano R. Quantification of coronary artery calcium using ultrafast computed tomography. J Am Coll Cardiol 1990;15:827-32.
18. Ix JH, Katz R, Kestenbaum B, Fried LF, Kramer H, Stehman-Breen C, Shlipak MG. Association of mild to moderate kidney dysfunction and coronary calcification. J Am Soc Nephrol 2008;19: 579-85.
19. Januzzi JL Jr, Bamberg F, Lee H, Truong QA, Nichols JH, Karakas M, et al. High-sensitivity troponin T concentrations in acute chest pain patients evaluated with cardiac computed tomography. Circulation 2010;121:1227-34.
20. Hemmelgarn BR, Manns BJ, Lloyd A, James MT, Klarenbach S, Quinn RR, et al. Relation between kidney function, proteinuria, and adverse outcomes. JAMA 2010;303:423-9.
21. Peralta CA, Shlipak MG, Judd S, Cushman M, McClellan W, Zakai NA, et al. Detection of chronic kidney disease with creatinine, cystatin C, and urine albumin-to-creatinine ratio and association with progression to end-stage renal disease and mortality. JAMA 2011;305:1545-52.
22. Perkovic V, Verdon C, Ninomiya T, Barzi F, Cass A, Patel A, et al. The relationship between proteinuria and coronary risk: a systematic review and meta-analysis. PLoS Med 2008;5:e207.
23. Ricchiuti V, Voss EM, Ney A, Odland M, Anderson PA, Apple FS. Cardiac troponin T isoforms expressed in renal diseased skeletal muscle will not cause false-positive results by the second generation cardiac troponin T assay by Boehringer Mannheim. Clin Chem 1998;44:1919 -24.
24. Mall G, Rambausek M, Neumeister A, Kollmar S, Vetterlein F, Ritz E. Myocardial interstitial fibrosis in experimental uremia: implications for cardiac compliance. Kidney Int 1988;33:804 -11.
25. Faul C, Amaral AP, Oskouei B, Hu MC, Sloan A, Isakova T, et al. FGF23 induces left ventricular hypertrophy. J Clin Invest 2011;12:4393- 408.
26. Tsutamoto T, Kawahara C, Yamaji M, Nishiyama K, Fujii M, Yamamoto T, Horie M. Relationship between renal function and serum cardiac troponin T in patients with chronic heart failure. Eur J Heart Fail 2009;11:653- 8.
27. Freda BJ, Tang WH, Van Lente F, Peacock WF, Francis GS. Cardiac troponins in renal insufficiency: review and clinical implications. J Am Coll Cardiol 2002;40:2065-71.
28. Lamb EJ, Kenny C, Abbas NA, John RI, Webb MC, Price CP, Vickery S. Cardiac troponin I concentration is commonly increased in nondialysis patients with CKD: experience with a sensitive assay. Am J Kidney Dis 2007;49:507-16.
29. Kavsak PA, Jaffe AS. High-sensitivity cardiac troponin assays: change is important. Clin Chem 2012;58:311-3.